Skip to content
lifestyle.ucconnection.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Ayrmid Pharma Ltd
Ayrmid Appoints Ideogen for Omisirge(R) in EMEA
September 1, 2026
Ayrmid and Ariti Sign Distribution Agreement for Omisirge(R) in Greece and Cyprus
February 10, 2026
Ayrmid Pharma Ltd Announces Additional Positive Results for Omisirge(R) in Treating Severe Aplastic Anemia (SAA) Presented at TANDEM
February 10, 2026
Ayrmid Reports Additional New Real-World Data on Motixafortide for Stem Cell Mobilization in Sickle Cell Disease and Beta-Thalassemia
February 10, 2026